Olympus Corp. · TSE:7733

Olympus — Olympus Corp Ord — Q2 2026 Earnings Presentation

14 slides from Olympus's earnings presentation, Nov 7, 2025

  1. Slide 1: Olympus Corporate Strategy

    Olympus Corporate Strategy Where Purpose Meets Performance Olympus Corporate Strategy November 7, 2025 INTERNAL USE ONLY

  2. Slide 2: Disclaimer

    Disclaimer  This material contains forward-looking statements that reflect management’s current views, plans, and expectations based on information available at the time of preparation. These forward-looking statements are not guarantees of future performance and involve known and unknown risks, unc

  3. Slide 3: Global trends show increasing demand for endoscopy procedures

    Global trends show increasing demand for endoscopy procedures, underpinned by macroeconomic factors and the need for better care Global demand drives 5% annual growth of 600M endoscopy-enabled care 1 Potential global  Aging populations (>40% of the global population over 60) procedures3  Growing p

  4. Slide 4: A new vision for endoscopy-enabled care is needed

    A new vision for endoscopy-enabled care is needed to deliver against healthcare needs and opportunities Patients Clinicians Administrators Endoscopy that’s advanced and less invasive Endoscopy made safer, smarter, Advanced technology drives effi ciency and brings clarity and comfort. and more consiste

  5. Slide 5: Olympus is best positioned to deliver on that future

    Olympus is best positioned to deliver on that future A Backbone of Advanced Endoscopes and Smart Technologies Scalable Endoscopy Therapeutic Devices Driving the Future Largest installed base of interoperable Broad portfolio of scopes and therapeutic AI, robotics, and workflow management towers for sc

  6. Slide 6: GIS & SIS will fortify portfolios with near term launches

    GIS & SIS will fortify portfolios with near term launches that drive the majority of incremental growth Olympus market position FY26 FY26 FY27 FY28 EVIS X1 Scopes (EZ/EDOF) US, China EVIS X1 Scopes (Additional line-up) US, EU, JP China 1st GI NextGen Monitors EU, JP, China US EUS System & Scopes US,

  7. Slide 7: Olympus is accelerating investments in the Endosuite of the future

    Olympus is accelerating investments in the Endosuite1 of the future Integrate AI into the Build robotic endoluminal Expand advanced diagnostic endoscopy ecosystem solutions and therapeutic portfolio OLYSENSE CAD/AI launched Swan EndoSurgical and other Develop, partner, and acquire advanced commercia

  8. Slide 8: Envisioning the future of endoscopy-enabled care

    Envisioning the future of endoscopy-enabled care Better care Powered by an integrated ecosystem Detect diseases earlier Expanding minimally- Enabling more Driving Ecosystem of cloud connected Integrated data to Same day diagnosis, invasive therapeutic diseases to be efficiencies hardware, devices, sof

  9. Slide 9: A bold vision requires bold steps to create a more effective organization

    A bold vision requires bold steps to create a more effective and efficient organization FY26-27 FY27+ Operating Model Organization Health Accelerate Productivity Shifting from a region-led model ~2,000 ~24B JPY to a simpler matrix with division Net position reductions1 Run-rate savings target1 as the l

  10. Slide 10: Our vision, pipeline and restructuring form the basis of our multi-year financial plan

    Our vision, pipeline and restructuring form the basis of our multi-year financial plan We aim to achieve 3% 1 growth in FY27, 4% 1 in FY28, and 5% 1 in FY29, with ~100 bps of margin expansion in each of these years from FY26 as the base year. Drivers  Global access for the best-in-class EVIS X1 endo

  11. Slide 11: Where purpose meets performance: Shaping the future of endoscopy-enabled care

    Where purpose meets performance: Shaping the future of endoscopy-enabled care OUR PURPOSE Making people’s lives healthier, safer and more fulfilling OUR STRATEGIC PILLARS Innovation-Driven Growth Simplicity Accountability Lead the next wave of innovation & Simplify Olympus to Instill a high-performan

  12. Slide 12: OLYMPUS

    OLYMPUS

  13. Slide 13: Appendix

    Appendix

  14. Slide 14: Capital allocation policy

    Capital allocation policy  Prioritize allocation to business investment  Stable and gradual dividend increase  Flexible buyback of company shares Prioritize Business Investment  Investment for profitable, organic growth  Strategic investment for growth opportunities Stable and gradual dividend i

Olympus Corp Ord — Q2 2026 Earnings Presentation on 6ix